OtherResearch
Mycoplasma clearance and risk analysis in a model bioprocess
Julie Wang, Sarah Johnson, Matthew Brown, Scott Lute, Cyrus Agarabi, Alena Dabrazhynetskaya, Vladimir Chizhikov and Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology January 2017, pdajpst.2016.007054; DOI: https://doi.org/10.5731/pdajpst.2016.007054
Julie Wang
1 CDER/FDA;
Sarah Johnson
1 CDER/FDA;
Matthew Brown
1 CDER/FDA;
Scott Lute
1 CDER/FDA;
Cyrus Agarabi
1 CDER/FDA;
Alena Dabrazhynetskaya
2 CBER/FDA
Vladimir Chizhikov
2 CBER/FDA
Kurt Brorson
1 CDER/FDA;
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Mycoplasma clearance and risk analysis in a model bioprocess
Julie Wang, Sarah Johnson, Matthew Brown, Scott Lute, Cyrus Agarabi, Alena Dabrazhynetskaya, Vladimir Chizhikov, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Jan 2017, pdajpst.2016.007054; DOI: 10.5731/pdajpst.2016.007054
Mycoplasma clearance and risk analysis in a model bioprocess
Julie Wang, Sarah Johnson, Matthew Brown, Scott Lute, Cyrus Agarabi, Alena Dabrazhynetskaya, Vladimir Chizhikov, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Jan 2017, pdajpst.2016.007054; DOI: 10.5731/pdajpst.2016.007054
Jump to section
Related Articles
- No related articles found.
Cited By...
More in this TOC Section
Similar Articles